OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination Therapy with Anti–CTL Antigen-4 and Anti-4-1BB Antibodies Enhances Cancer Immunity and Reduces Autoimmunity

HTML

Year: 2006
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-05-2128
Authors: Ergun Kocak, Kenneth Lute, Xing Chang, Kenneth F. May, Katie R. Exten, Huiming Zhang, Shahab F. Abdessalam, Amy M. Lehman, David Jarjoura, Pan Zheng, Yang Liu
Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, University of Michigan
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CTLA-4, 4-1BB, anti-CTLA-4 antibody, combination immunotherapy, antitumor immunity, autoimmunity, regulatory T cells, CD8+ T cells, tumor rejection, MC38 colon carcinoma, B16 melanoma, immune checkpoint blockade
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Awards: Innate Immunity: Elucidation and Modulation for Cancer Therapy, CD24 in Cancer Resistance and Immunotherapy, B7 RECEPTORS, TUMOR IMMUNOTHERAPY AND IMMUNE REGULATION, Human gene knock-in mice and anti-cancer antibodies
OpenAlex ID: W2109490990
FWCI: 6.359
Cites: 51
Cited by: 185
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms